Regarding the expression in stromal immune cells, both PD-L1 and PD-L2 were detected in 80 (26.3%) and 59 (19.4%) of the tumor samples, respectively (Figure 1C, Table 1). The gene discussed is PDCD1LG2; the disease is neoplasm.